OMNI Receives FDA Clearance for Robotic Tissue Balancing Device on OMNIBotics Platform

OMNIlife science received FDA 510(k) clearance to market Active Spacer, a proprietary robotic tissue balancing device for use with OMNIBotics® robotic-assisted total knee replacement (TKR) technology.

Active Spacer, which has been in clinical use in Australia since 1Q17, provides management of surrounding soft tissue with real-time...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us